P51 Phase 1/2 study to evaluate AOC 1020 for adult patients with facioscapulohumeral muscular dystrophy: FORTITUDE trial design
| Autor: | Halseth, A., Ackermann, E., Brandt, T., Chen, C., Cho, H., Stahl, M., DiTrapani, K., Hughes, S., Tawil, R., Statland, J. |
|---|---|
| Zdroj: | In Neuromuscular Disorders October 2023 33 Supplement 1:S71-S71 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect